He highlighted that while Pharma GCCs have made significant progress, the challenge is no longer whether they can become innovation hubs, but how to get there. He emphasized that moving beyond a process mindset to a product mindset, deepening functional and domain expertise, and embracing technologies like Agentic AI are critical to breaking out of efficiency traps.
